Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2026

Conditions
Macular Edema (ME)Non Infectious Uveitis
Interventions
DRUG

Suprachoroidal triamcinolone acetonide injection

For suprachoroidal injection, we developed a custom-made delivery system to access the potential suprachoroidal space. A 1 mL tuberculin syringe fitted with a 27-gauge needle was prepared, and a plastic sleeve from a 24-26 G IV cannula was placed over the needle as a spacer to control penetration depth.

Trial Locations (1)

10064

RECRUITING

Ibn Al-Haitham Eye Teaching Hospital, Baghdad

All Listed Sponsors
lead

Baghdad college of medicine

OTHER